Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 11473 | 912 | 28.3 | 56% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 477 | 14988 | PRE ECLAMPSIA//HYPERTENSION IN PREGNANCY//HELLP SYNDROME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY | Journal | 7 | 17% | 4% | 38 |
| 2 | PREECLAMPSIA PREVENTION | Author keyword | 4 | 67% | 0% | 4 |
| 3 | LOW DOSE ASPIRIN | Author keyword | 4 | 15% | 3% | 27 |
| 4 | ANGIOTENSIN SENSITIVITY TEST | Author keyword | 2 | 67% | 0% | 2 |
| 5 | GYNECOL OBSTET NEONATOL CLIN | Address | 2 | 67% | 0% | 2 |
| 6 | CHORIONIC VESSELS | Author keyword | 1 | 50% | 0% | 2 |
| 7 | POTENTIATION OF PLATELET COLLAGEN ACTIVATION | Author keyword | 1 | 100% | 0% | 2 |
| 8 | ROLLOVER TEST | Author keyword | 1 | 50% | 0% | 2 |
| 9 | THIOFEDRINE | Author keyword | 1 | 100% | 0% | 2 |
| 10 | UMBILICOPLACENTAL VESSELS | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VASOACTIVE AUTACOIDS | 12 | 86% | 1% | 6 |
| 2 | II PRESSOR RESPONSES | 8 | 70% | 1% | 7 |
| 3 | CHORIONIC VEINS | 8 | 75% | 1% | 6 |
| 4 | DECREASED PROSTACYCLIN PRODUCTION | 8 | 100% | 1% | 5 |
| 5 | PROSTAGLANDIN F CONCENTRATIONS | 4 | 75% | 0% | 3 |
| 6 | II PRESSOR RESPONSE | 3 | 50% | 1% | 5 |
| 7 | ANGIOTENSIN SENSITIVITY TEST | 3 | 45% | 1% | 5 |
| 8 | PLACENTAL PROSTACYCLIN | 2 | 36% | 1% | 5 |
| 9 | DECREASED PROSTACYCLIN | 2 | 67% | 0% | 2 |
| 10 | INDUCED HYPERTENSIVE DISORDERS | 2 | 67% | 0% | 2 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY | 7 | 17% | 4% | 38 |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review | 2001 | 99 | 46 | 78% |
| Antiplatelet agents for preventing pre-eclampsia and its complications (Review) | 2007 | 101 | 91 | 66% |
| Eicosanoids in preeclampsia | 2004 | 51 | 84 | 49% |
| LOW-DOSE ASPIRIN - LACK OF ASSOCIATION WITH AN INCREASE IN ABRUPTIO PLACENTAE OR PERINATAL-MORTALITY | 1995 | 29 | 9 | 100% |
| PREECLAMPSIA - A REVIEW OF THE ROLE OF PROSTAGLANDINS | 1988 | 232 | 53 | 51% |
| Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the US Preventive Services Task Force | 2014 | 18 | 65 | 31% |
| Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis | 2001 | 51 | 17 | 59% |
| Aspirin for prevention of preeclampsia in women with historical risk factors: A systematic review | 2003 | 76 | 34 | 44% |
| LOW-DOSE ASPIRIN IN THE PREVENTION OF PREECLAMPSIA AND FETAL GROWTH-RETARDATION - RATIONALE, MECHANISMS, AND CLINICAL-TRIALS | 1993 | 72 | 59 | 51% |
| Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation | 2014 | 6 | 48 | 33% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GYNECOL OBSTET NEONATOL CLIN | 2 | 67% | 0.2% | 2 |
| 2 | MED PHYSIOL CELL BIOL | 1 | 27% | 0.3% | 3 |
| 3 | CHILDRENS HOSP SERV | 1 | 50% | 0.1% | 1 |
| 4 | OSTET GINECOL CLIN 1 | 1 | 50% | 0.1% | 1 |
| 5 | FIKRET BIYAL CENT BIOCHEM | 0 | 33% | 0.1% | 1 |
| 6 | HYPERTENS DISORDERS PREGNANCY SERV | 0 | 33% | 0.1% | 1 |
| 7 | MED UNIT REPROD MED | 0 | 33% | 0.1% | 1 |
| 8 | PHARMACOL VASC PERINATALE | 0 | 33% | 0.1% | 1 |
| 9 | COMIS COORDINADORA | 0 | 20% | 0.1% | 1 |
| 10 | FRAUENKLIN 2 | 0 | 20% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000248182 | UNITAT ANAT HUMANA EMBRIOL//UNITAT MED MATERNO FETAL//THROMBIN ANTITHROMBIN COMPLEXES |
| 2 | 0.0000191741 | PERINATAL S//UTERINE ARTERY//UTERINE CIRCULATION |
| 3 | 0.0000172571 | CHRONIC HYPERTENSION//CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY//LABETALOL |
| 4 | 0.0000136847 | THROMBOXANE A2 PROSTACYCLIN BALANCE//SIGNALISAT REGULAT CELLULAI//U361 |
| 5 | 0.0000135911 | PROSTACYCLIN STIMULATING FACTOR//CANINE PLATELET//CELLULAR METABOLITES |
| 6 | 0.0000128944 | BIOENERGET CELULAR//PG BIOCHEM//BIOL TOXICOL PHARMACOL |
| 7 | 0.0000124026 | CARANE DERIVATIVES//AII RECEPTORS//BLOOD PLATELET |
| 8 | 0.0000123328 | MATERNAL CARDIAC FUNCTION//ATRIAL VOLUME RECEPTORS//3 ALPHA HYDROXY DIHYDROPROGESTERONE |
| 9 | 0.0000121084 | AMINO ACID TRANSFER//CHOLINE ACETYLTRANSFERASE INHIBITORS//MED MED ANESTHESIOL |
| 10 | 0.0000095408 | PRE ECLAMPSIA//SOLUBLE FMS LIKE TYROSINE KINASE 1//SOLUBLE ENDOGLIN |